PABVX | VMVAX | PABVX / VMVAX | |
Total Expense Ratio | 0.88 | 0.07 | 1,257% |
Annual Report Gross Expense Ratio | 0.90 | 0.07 | 1,286% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 3.316 | 5.198 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.31B | 31B | 7% |
Annual Yield % from dividends | 1.22 | 2.22 | 55% |
Returns for 1 year | -9.53 | 7.67 | -124% |
Returns for 3 years | -4.62 | 17.51 | -26% |
Returns for 5 years | 28.14 | 65.15 | 43% |
Returns for 10 years | 17.59 | 87.87 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PREPX | 26.91 | 0.15 | +0.56% |
Principal Real Estate Securities R5 | |||
RYZAX | 111.68 | 0.05 | +0.04% |
Rydex S&P 500 Pure Value H | |||
HRCCX | 31.36 | -0.10 | -0.32% |
Carillon ClariVest Capital Apprec C | |||
CAPEX | 2862.94 | -9.66 | -0.34% |
Eaton Vance Tx-Mgd Growth 1.0 | |||
BMIYX | 7.41 | -0.04 | -0.54% |
BNY Mellon Income Stock Y |